Aeluma (ALMU) Q3 2026 earnings review
Narrative Outpaces Financial Reality as Guidance is Slashed
Aeluma's Q3 results present a stark contrast between an exciting AI photonics narrative and a sobering income statement. While management successfully secured $5 million in new R&D contracts, actual recognized revenue decelerated to $1.2 million, down slightly YoY. More alarmingly, government-related execution delays forced a massive cut to the top-end of FY26 revenue guidance. With operating expenses surging to support future manufacturing scale, Adjusted EBITDA losses have deepened. A strong $37.8 million cash pile buys the company time, but the math behind the narrowed guidance implies a brutal revenue cliff in the upcoming Q4.
🐂 Bull Case
Aeluma met its FY26 target of 3-7 new engagements early, signing 6 new contracts worth $5 million. This non-dilutive funding validates the technology platform for government and defense applications.
Announced critical partnerships with Tower Semiconductor and Sumitomo Chemical. This solves a major bottleneck for the company, clearing the path from R&D prototyping to volume production.
🐻 Bear Case
The company narrowed its FY26 revenue guidance to $4.2-$4.6M. Given that Aeluma has already generated $3.88M in the first nine months, this implies Q4 revenue will be just $0.32M to $0.72M—a massive deceleration.
Total operating expenses jumped 60% YoY to $3.3 million. The company is staffing up for commercialization, but with current revenues stalling, the cash burn rate is accelerating.
⚖️ Verdict: 🔴
Bearish. The long-term AI data center thesis is compelling, but investors should not ignore the immediate financial math. A 23% cut to the guidance ceiling and an implied Q4 revenue drop outweigh the positive contract announcements.
Key Themes
The Q4 Implied Revenue Cliff
The most critical data point in this report is buried in the math. Nine-month FY26 revenue sits at $3.88M. Management's new FY26 guidance is $4.2M-$4.6M. Subtracting the 9-month actuals leaves an implied Q4 revenue of just $0.32M to $0.72M. At the midpoint ($0.52M), this represents a 60% YoY collapse compared to Q4 FY25's $1.32M. This is a severe deceleration.
Overexposure to Government Timelines
Management directly blamed 'government shutdowns and other factors' for delaying the start-of-work on several projects, forcing the guidance cut. While the $5M in new contract wins is a strong positive, it highlights a structural vulnerability: Aeluma remains highly dependent on public sector bureaucratic timelines to recognize revenue.
Accelerating Cash Burn to Support Scale
Operating expenses jumped from $2.1M a year ago to $3.3M this quarter. General & Administrative expenses alone rose 25% to $1.6M, while R&D nearly doubled to $0.88M. Management attributes this to key senior hires and operations scaling. This trend is accelerating, meaning profitability is moving further out of reach until commercial product revenue materializes.
Indium Phosphide Supply Chain Gap
The company's core thesis remains intact: the massive AI data center buildout requires advanced photonics, and the industry is constrained by Indium Phosphide availability. Customers are actively engaging Aeluma to bridge near-term supply gaps, validating the core technology platform.
Path to Volume Manufacturing Cleared
Transitioning from R&D to commercial scale requires heavy-hitting foundry partners. The formal addition of Tower Semiconductor and Sumitomo Chemical Advanced Technology to Aeluma's supply chain is a major milestone. It proves to prospective commercial customers that Aeluma can deliver in volume.
Other KPIs
Stable. Down slightly from $38.6M at the end of December 2025. Following their successful public offering earlier in the fiscal year, Aeluma has secured a massive liquidity runway. This cash buffer is the company's strongest asset, allowing them to absorb the current operating losses while waiting for commercial contracts to ramp.
Reversing. A year ago, the company posted a slight positive EBITDA of $109k. The recent quarters represent a structural reversal into deeper losses (-$917k in Q2, -$911k in Q3) as the company prioritizes team expansion and manufacturing readiness over near-term profitability.
Guidance
Decelerating significantly. The company slashed the top end of its prior guidance ($4.0 - $6.0 million) by $1.4 million. Given the $3.88M already recognized year-to-date, this target implies an average Q4 midpoint revenue of just $0.52 million. Management attributes the shortfall to delayed project start dates caused by government shutdowns.
Key Questions
Visibility into FY27
With the start of several government contracts pushed out, how much of the $1.4 million removed from the top end of FY26 guidance will directly roll into Q1 or Q2 of FY27?
Commercial Revenue Timeline
The company highlighted $5 million in new development engagements. Are any of these engagements expected to transition from R&D to commercial product orders within the next 12 months?
Cash Burn Plateau
With operating expenses jumping to $3.3 million this quarter, have we reached a stabilized run-rate for OpEx, or should investors expect continued aggressive headcount expansion through the rest of the calendar year?